🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 17 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/02/2000 | 78,84 | 88,90 | 78,84 | 85,62 | +10,57% | 12,76% | 378.842 |
| 16/02/2000 | 70,65 | 78,13 | 66,91 | 77,43 | +10,33% | 15,89% | 256.427 |
| 15/02/2000 | 72,05 | 72,05 | 63,86 | 70,18 | -0,66% | 11,36% | 129.469 |
| 14/02/2000 | 71,12 | 72,75 | 66,91 | 70,65 | +7,09% | 8,22% | 163.506 |
| 11/02/2000 | 71,12 | 74,39 | 65,03 | 65,97 | -6,93% | 13,16% | 293.242 |
| 10/02/2000 | 61,76 | 71,12 | 61,29 | 70,88 | +15,65% | 15,91% | 281.033 |
| 09/02/2000 | 62,69 | 64,10 | 60,82 | 61,29 | -2,24% | 5,22% | 165.777 |
| 08/02/2000 | 62,46 | 63,63 | 61,29 | 62,69 | +1,90% | 3,75% | 180.338 |
| 07/02/2000 | 56,61 | 62,23 | 55,68 | 61,53 | +15,35% | 11,57% | 378.762 |
| 04/02/2000 | 56,14 | 56,38 | 52,40 | 53,34 | -4,20% | 7,08% | 116.511 |
| 03/02/2000 | 58,02 | 58,02 | 54,27 | 55,68 | -2,46% | 6,45% | 74.700 |
| 02/02/2000 | 53,81 | 58,72 | 53,81 | 57,08 | +2,95% | 9,13% | 140.289 |
| 01/02/2000 | 50,76 | 55,68 | 50,53 | 55,44 | +5,80% | 10,14% | 97.596 |
| 31/01/2000 | 53,81 | 53,81 | 46,79 | 52,40 | -0,44% | 13,04% | 190.383 |
| 28/01/2000 | 56,38 | 56,38 | 52,40 | 52,64 | -6,64% | 7,05% | 168.582 |
| 27/01/2000 | 58,02 | 58,48 | 56,14 | 56,38 | -3,60% | 4,03% | 108.443 |
| 26/01/2000 | 58,02 | 59,42 | 57,08 | 58,48 | +0,40% | 4,03% | 129.389 |
| 25/01/2000 | 63,16 | 63,86 | 57,55 | 58,25 | -7,43% | 10,00% | 125.328 |
| 24/01/2000 | 60,82 | 64,57 | 60,36 | 62,93 | +4,26% | 6,92% | 246.969 |
| 21/01/2000 | 60,59 | 62,23 | 57,08 | 60,36 | -0,39% | 8,49% | 151.777 |
| 20/01/2000 | 60,36 | 61,06 | 59,19 | 60,59 | +1,57% | 3,10% | 133.450 |
| 19/01/2000 | 59,65 | 60,12 | 54,74 | 59,65 | -1,92% | 9,02% | 114.775 |
| 18/01/2000 | 60,59 | 62,23 | 51,70 | 60,82 | -1,52% | 17,37% | 239.461 |
| 14/01/2000 | 62,23 | 65,97 | 60,36 | 61,76 | +0,00% | 9,02% | 191.024 |
| 13/01/2000 | 57,55 | 62,23 | 57,55 | 61,76 | +7,32% | 8,13% | 224.126 |
| 12/01/2000 | 58,95 | 58,95 | 53,81 | 57,55 | -2,38% | 8,73% | 204.837 |
| 11/01/2000 | 57,31 | 63,63 | 57,08 | 58,95 | +5,88% | 11,43% | 486.591 |
| 10/01/2000 | 52,40 | 56,14 | 52,17 | 55,68 | +8,68% | 7,59% | 291.639 |
| 07/01/2000 | 50,76 | 52,64 | 50,76 | 51,23 | +0,00% | 3,69% | 237.965 |
| 06/01/2000 | 49,36 | 51,23 | 48,42 | 51,23 | +4,29% | 5,69% | 95.111 |